48,550 Shares in CVS Health Corporation $CVS Acquired by Madison Asset Management LLC

Madison Asset Management LLC acquired a new position in shares of CVS Health Corporation (NYSE:CVS) during the 2nd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor acquired 48,550 shares of the pharmacy operator’s stock, valued at approximately $5,022,000.

Several other hedge funds and other institutional investors also recently made changes to their positions in CVS. Beaird Harris Wealth Management LLC boosted its position in shares of CVS Health by 201.0% during the second quarter. Beaird Harris Wealth Management LLC now owns 292 shares of the pharmacy operator’s stock worth $30,000 after purchasing an additional 195 shares in the last quarter. J.Safra Asset Management Corp acquired a new stake in CVS Health during the 2nd quarter worth $30,000. Dunhill Financial LLC bought a new position in CVS Health during the second quarter worth about $32,000. Swiss RE Ltd. acquired a new position in CVS Health in the fourth quarter valued at about $26,000. Finally, Sankala Group LLC bought a new stake in shares of CVS Health in the fourth quarter worth about $28,000. 80.66% of the stock is owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

CVS has been the topic of several recent analyst reports. UBS Group lifted their price objective on CVS Health from $122.00 to $126.00 and gave the company a “buy” rating in a report on Thursday, August 6th. Argus raised their target price on shares of CVS Health from $104.00 to $114.00 and gave the stock a “buy” rating in a report on Wednesday. Cantor Fitzgerald lifted their price target on shares of CVS Health from $100.00 to $110.00 and gave the company an “overweight” rating in a research note on Tuesday, July 7th. Piper Sandler reiterated an “overweight” rating and issued a $113.00 price target on shares of CVS Health in a report on Monday, June 1st. Finally, Wells Fargo & Company increased their price objective on shares of CVS Health from $103.00 to $123.00 and gave the stock an “overweight” rating in a research report on Monday, July 13th. Twenty-two equities research analysts have rated the stock with a Buy rating and two have assigned a Hold rating to the company’s stock. According to MarketBeat, the company presently has an average rating of “Moderate Buy” and a consensus price target of $107.17.

CVS Health Trading Up 0.2%

Shares of NYSE:CVS opened at $93.83 on Friday. The company has a market capitalization of $120.01 billion, a P/E ratio of 24.82, a P/E/G ratio of 0.89 and a beta of 0.61. CVS Health Corporation has a 1 year low of $69.51 and a 1 year high of $110.68. The company has a debt-to-equity ratio of 0.74, a current ratio of 0.87 and a quick ratio of 0.66. The business’s 50 day simple moving average is $102.19 and its 200 day simple moving average is $88.83.

CVS Health (NYSE:CVS) last announced its quarterly earnings data on Wednesday, August 5th. The pharmacy operator reported $2.58 earnings per share for the quarter, beating the consensus estimate of $1.87 by $0.71. The firm had revenue of $106.10 billion during the quarter, compared to analysts’ expectations of $100.03 billion. CVS Health had a return on equity of 13.12% and a net margin of 1.18%.The company’s quarterly revenue was up 7.3% compared to the same quarter last year. During the same period in the previous year, the firm earned $1.81 EPS. CVS Health has set its FY 2026 guidance at 7.900-8.100 EPS. On average, research analysts anticipate that CVS Health Corporation will post 8.02 EPS for the current fiscal year.

CVS Health Announces Dividend

The business also recently declared a quarterly dividend, which was paid on Monday, August 3rd. Investors of record on Thursday, July 23rd were paid a $0.665 dividend. This represents a $2.66 dividend on an annualized basis and a yield of 2.8%. The ex-dividend date of this dividend was Thursday, July 23rd. CVS Health’s payout ratio is 70.37%.

CVS Health Profile

CVS Health Corporation is a diversified healthcare company that operates a large network of retail pharmacies, pharmacy benefit management services and health care solutions. Headquartered in Woonsocket, Rhode Island, the company traces its roots to the early 1960s and has grown into an integrated provider of prescription drugs, over‑the‑counter products, clinical services and health insurance offerings. Its operating model combines retail pharmacy locations and in‑store clinics with broader pharmacy and health plan capabilities.

Key business activities include CVS Pharmacy retail operations, MinuteClinic walk‑in medical clinics and HealthHUB locations that offer expanded clinical services.